Home›Companies›Biotech & Pharma›Neurofold Therapeutics

Neurofold Therapeutics Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Jul 14, 2026·Suggest an edit

About Neurofold Therapeutics

Neurofold Therapeutics is a private company based in Greenwood Village, Colorado, incorporated in 2024 in Delaware. It has reported $6,499,987 raised in one offering on Form D since July 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 25, 2026Jul 14, 2026$6,499,987fully sold18$361KEquity, SAFE (Simple Agreement for Future Equity)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Neurofold Therapeutics's Form D filed Jul 14, 2026.

GB
RK
Rajeev Kumar
Executive officer and director

Sources

  1. SECNeurofold Therapeutics Inc. filing history